KCM
Kynam Capital Management Portfolio holdings
AUM
$929M
This Quarter Return
+31.72%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$884M
AUM Growth
+$884M
(+47%)
Cap. Flow
+$129M
Cap. Flow
% of AUM
14.56%
Top 10 Holdings %
Top 10 Hldgs %
80.12%
Holding
32
New
3
Increased
10
Reduced
5
Closed
7
Top Buys
| 1 |
Syndax Pharmaceuticals
SNDX
|
$44.5M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$42.2M |
| 3 |
MOR
MorphoSys AG American Depositary Shares
MOR
|
$41.9M |
| 4 |
Cogent Biosciences
COGT
|
$21.4M |
| 5 |
Dynavax Technologies
DVAX
|
$14.2M |
Top Sells
| 1 |
Natera
NTRA
|
$37.8M |
| 2 |
Vaxcyte
PCVX
|
$18.8M |
| 3 |
Taysha Gene Therapies
TSHA
|
$10.4M |
| 4 |
Celldex Therapeutics
CLDX
|
$7.7M |
| 5 |
Olema Pharmaceuticals
OLMA
|
$2.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Natera
NTRA
$23.1B
| $150M | 16.66% | 2,400,000 -603,668 | -20% | -$37.8M |
|
|
2
Syndax Pharmaceuticals
SNDX
$1.41B
| $122M | 13.55% | 5,660,000 +2,060,000 | +57% | +$44.5M |
|
|
3
Celldex Therapeutics
CLDX
$1.47B
| $119M | 13.21% | 3,005,904 -194,096 | -6% | -$7.7M |
|
|
4
Vaxcyte
PCVX
$4B
| $63M | 6.97% | 1,002,407 -300,000 | -23% | -$18.8M |
|
5
Vera Therapeutics
VERA
$1.38B
| $56.1M | 6.22% | 3,650,339 +694,286 | +23% | +$10.7M |
|
6
Protagonist Therapeutics
PTGX
$3.67B
| $46M | 5.09% | 2,004,875 +186,218 | +10% | +$4.27M |
|
|
IMGN
7
DELISTED
Immunogen Inc
IMGN
| $42.2M | 4.67% | +1,422,503 | New | +$42.2M |
|
|
MOR
8
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $41.9M | 4.64% | +4,234,685 | New | +$41.9M |
|
|
9
Cogent Biosciences
COGT
$1.69B
| $34.4M | 3.81% | 5,854,766 +3,644,641 | +165% | +$21.4M |
|
10
Liquidia Corp
LQDA
$2.38B
| $32.5M | 3.6% | 2,698,324 +698,324 | +35% | +$8.4M |
|
11
BioCryst Pharmaceuticals
BCRX
$1.74B
| $27.6M | 3.05% | 4,600,000 +1,466,807 | +47% | +$8.79M |
|
|
TSVT
12
DELISTED
2seventy bio
TSVT
| $25.4M | 2.82% | 5,953,825 | – | – |
|
|
13
Dynavax Technologies
DVAX
$1.19B
| $21.2M | 2.35% | 1,514,383 +1,014,383 | +203% | +$14.2M |
|
14
Wave Life Sciences
WVE
$1.53B
| $19.9M | 2.2% | 3,932,082 | – | – |
|
15
Travere Therapeutics
TVTX
$1.56B
| $18M | 1.99% | 2,000,000 +1,042,498 | +109% | +$9.37M |
|
16
Viridian Therapeutics
VRDN
$1.5B
| $13.2M | 1.47% | 607,915 -91,766 | -13% | -$2M |
|
|
AMRN
17
Amarin Corp
AMRN
$311M
| $10.5M | 1.16% | 12,022,957 | – | – |
|
|
SLRN
18
DELISTED
ACELYRIN
SLRN
| $8.95M | 0.99% | 1,200,000 | – | – |
|
19
Sutro Biopharma
STRO
$72.7M
| $8.59M | 0.95% | 2,001,727 +449,052 | +29% | +$1.93M |
|
|
BNR
20
Burning Rock Biotech
BNR
$93.6M
| $8.09M | 0.9% | 8,694,426 +194,426 | +2% | +$181K |
|
21
Caribou Biosciences
CRBU
$174M
| $6.12M | 0.68% | 1,068,527 | – | – |
|
22
Tyra Biosciences
TYRA
$675M
| $4.71M | 0.52% | +340,190 | New | +$4.71M |
|
|
CNTA
23
Centessa Pharmaceuticals
CNTA
$2.25B
| $3.52M | 0.39% | 442,704 -287,768 | -39% | -$2.29M |
|
|
CNTB
24
Connect Biopharma
CNTB
$115M
| – | – | -535,005 | Closed | -$434K |
|
25
Corcept Therapeutics
CORT
$7.35B
| – | – | 0 | – | – |
|